K. Umino
发表
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
International Journal of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
Leukemia & lymphoma.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2017,
Acta Haematologica.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2017,
Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Leukemia & lymphoma.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
Cancer genetics.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2021,
Leukemia research.
S. Fujiwara,
Kazuya Sato,
H. Nakasone,
2019,
Acta Haematologica.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
Acta Haematologica.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2017,
Hematological oncology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2016,
Annals of Hematology.
Effect of cumulative daunorubicin dose on cardiotoxicity after allogeneic stem cell transplantation.
S. Fujiwara,
Kazuya Sato,
M. Ashizawa,
2022,
Leukemia research.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
Blood advances.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
International Journal of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
Acta histochemica et cytochemica.
H. Endo,
Kazuya Sato,
Y. Kanda,
2021,
Transplantation and cellular therapy.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
Transplant international : official journal of the European Society for Organ Transplantation.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Annals of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
International Journal of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2017,
International Journal of Hematology.
S. Fujiwara,
Kazuya Sato,
M. Ashizawa,
2023,
British journal of haematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2016,
Leukemia & lymphoma.
S. Fujiwara,
S. Hatakeyama,
Kazuya Sato,
2018,
Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
Annals of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Internal medicine.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
Annals of Hematology.
Daratumumab in first-line is cost-effective in transplant-eligible newly diagnosed myeloma patients.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2022,
Blood.
S. Fujiwara,
K. Sakamoto,
K. Kawamura,
2020,
Bone Marrow Transplantation.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2017,
Annals of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2017,
Leukemia & lymphoma.
S. Fujiwara,
Kazuya Sato,
Y. Kanda,
2018,
Leukemia & lymphoma.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2020,
Bone Marrow Transplantation.
S. Fujiwara,
Kazuya Sato,
M. Ashizawa,
2021,
Internal medicine.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
Clinical lymphoma, myeloma & leukemia.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
Clinical lymphoma, myeloma & leukemia.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
Annals of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2019,
Annals of Hematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2016,
Leukemia research.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
Leukemia & lymphoma.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
International Journal of Hematology.
H. Endo,
Kazuya Sato,
Y. Kanda,
2022,
British journal of haematology.
S. Fujiwara,
Kazuya Sato,
R. Yamasaki,
2018,
Annals of Hematology.
M. Ashizawa,
Y. Kanda,
D. Minakata,
2024,
International journal of hematology.
M. Ashizawa,
Y. Kanda,
D. Minakata,
2024,
Clinical transplantation.
Kazuya Sato,
R. Yamasaki,
M. Ashizawa,
2019,
Annals of Hematology.
M. Ashizawa,
Y. Kanda,
D. Minakata,
2024,
Leukemia & lymphoma.
Y. Kanda,
R. Ito,
Shin-ichiro Kawaguchi,
2024,
ImmunoHorizons.